tm logo
Trademark Search
ZYMOBYL

View On IC.GC.CA

ZYMOBYL
WITHDRAWN

on 31 Dec 1969

Last Applicant/ Owned by

AEGLEA BIOTHERAPEUTICS INC.

Barton Oaks Plaza One, Suite 250,901 S. MoPac ExpresswayAustin TX 78746

US

Serial Number

2026763 filed on 19th Mar 2020

ZYMOBYL

Trademark usage description

pharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of arginase 1 deficiency; biopha Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of rare genetic diseases; pharmaceutical preparations for the treatment of Arginase 1 deficiency; biopharmaceutical preparations for the treatment of rare genetic diseases; biopharmaceutical preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations for the treatment of rare genetic diseases; biotherapeutic preparations for the treatment of Arginase 1 deficiency; biotherapeutic preparations and substances for the treatment of rare genetic diseases; biotherapeutic preparations and substances for the treatment of Arginase 1 deficiency; enzyme replacement therapy preparations for medical purposes.

Classification kind code

11

Mark Details

Serial Number

2026763

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 27
on 25th Aug 2021		Approval Notice Sent
Submitted for opposition 26
on 25th Aug 2021		Approved
Submitted for opposition 22
on 19th Aug 2021		Search Recorded
Submitted for opposition 249
on 22nd Jul 2021		Withdrawn - Madrid Protocol
Submitted for opposition 256
on 08th Mar 2021		Notification of Possible Opposition Sent
Submitted for opposition 257
on 07th May 2020		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 06th May 2020		Formalized
Submitted for opposition 1
on 06th May 2020		Created
Submitted for opposition 228
on 19th Mar 2020		International Registration
Submitted for opposition 30
on 19th Mar 2020		Filed